Perinatal Outcomes In Monozygotic Pregnancies Resulting From Assisted Reproductive Technology Procedures: A Single-Center 6-Year Experience Based On A Large Cohort Of Pregnancies

Nur Dokuzeylul Gungor; Tugba Gurbuz

JBRA Assist. Reprod. 2023;27(1):29-34
ORIGINAL ARTICLE
doi: 10.5935/1518-0557.20220014

Perinatal Outcomes In Monozygotic Pregnancies Resulting From Assisted Reproductive Technology Procedures: A Single-Center 6-Year Experience Based On A Large Cohort Of Pregnancies

Nur Dokuzeylul Gungor¹, Tugba Gurbuz²

¹Associate Professor, Bahcesehir University Göztepe, Medical Park Hospital, IVF Unit, Istanbul, Turkey
²Associate Professor, Nisantasi University, Istanbul, Turkey

Received September 08, 2021
Accepted March 29, 2022

Corresponding author:
Nur Dokuzeylul Gungor
Bahcesehir University Göztepe
Medical Park Hospital
IVF Unit
Istanbul, Turkey
E-mail: drnur9eylul@hotmail.com

CONFLICT OF INTEREST
The authors have no conflict of interest to declare for the present study.

Authors’ contributions:
NUR DOKUZEYLUL GUNGOR designed the study and wrote the article. TUGBA GURBUZ collected and analyzed the data, revised and submitted the article.

ABSTRACT
Objective: Monozygotic twin (MZT) pregnancies increase the risk of maternal and infant mortality and include many complications. The present study describes our assisted reproductive technology (ART) procedures from the viewpoint of perinatal outcomes in MZT pregnancies.
Methods: In this retrospective clinical cross-sectional study, 1159 in vitro fertilization (IVF) cycles performed between October 2014 and December 2019 were reviewed and perinatal outcomes and general clinical conditions analyzed.
Results: Sixteen MZT pregnancies were observed, resulting in an incidence of 1.38%. The MZT pregnancy incidence for patients aged ≤35 and >35 years were 0.2% and 1.1%, respectively. Eight MZT pregnancies resulted in live births, while five ended in miscarriage. A significant positive correlation was found between the number of attempts and the age of female (r:0.674; p=0.004) and male (r:0.657; p=0.006) partners. Cumulus-Oocytes Complexes (COC) (r:0.635; p=0.008), Metaphase II Oocyte (MIIO) (r:0.627; p=0.009), Pronucleus Oocyte (PO) (r:0.585; p=0.017) were correlated with serum AMH levels. The number of MZT was positively correlated with male partner age (r:0.527; p=0.036) and negatively correlated with embryo transfer day (ETd) (r:-0.548; p=0.028).
Conclusions: The incidence of MZT pregnancies observed in this study was similar to the incidence reported in the literature, although risk was more pronounced among women aged >35 years. Due to potential risks for mothers and fetuses, MZT pregnancies may become a problem as the number of individuals seeking IVF continues to increase.

Keywords: Infertility, monozygotic twin, in vitro fertilization, miscarriage, maternal risk

INTRODUCTION
Generally regarded as the failure to perform reproductive function, infertility is a global health problem (Sarac & Koc, 2018). Although infertility treatments vary depending on the source of the problem, age, ovarian difficulty in egg release, drinking or smoking, intense physical and mental stress are also known to cause it (Eker et al., 2019; Inal et al., 2018). Assisted reproductive technology (ART) encompasses infertility treatments in which the fertilization of eggs and sperm occurs outside the human body (Aboulghar et al., 2020; Ballesta-Castillejos et al., 2019). It includes a roster of techniques such as pre-implantation genetic screening, embryo cultures, intracytoplasmic sperm injection, fresh or frozen embryo transfer, and in vitro fertilization (IVF) with donor oocytes (Cakiroglu & Tiras, 2020).
ART has been practiced for nearly 40 years, and more than a million babies have been born as a result of IVF. The use and effectiveness of IVF have increased over time (Calik & Bulut, 2020). Frozen embryo transfer and intracytoplasmic sperm injection have played a significant role in the achievement of strong reproductive results (Gurbuz et al., 2020). Multiple pregnancies account for more than 30% of all pregnancies resulting from ART, and more than half of newborns are the product of multiple pregnancies (Jančar et al., 2018). Prematurity and other complications may occur in these cases and, consequently, babies born from multiple pregnancies have higher rates of hospitalization and mortality compared to infants born from singleton pregnancies (Cavoretto et al., 2018).
The frequency of anomalies in multiple pregnancies is higher than in singleton pregnancies (Elias et al., 2020). Except for some problems that can be treated prenatally, non-vital anomalies cause new problems for both obstetricians and parents in multiple pregnancies (Dobrosavljevic et al., 2019). Although twin births account for 2% of all births, 8% of perinatal deaths occur in multiple pregnancy cases (Fernandes et al., 2016). Mortality is four times higher in multiple pregnancies than in singleton pregnancies and perinatal mortality is 19-32% (Zegers-Hochschild et al., 2017). Specific problems associated with high mortality in multiple pregnancies are common in monochorionic twins (Fineman et al., 2019). Monochorionic placentation increases the frequency of congenital anomalies in monozygotic twin (MZT) pregnancies. Compression-related deformations and lower extremity deformities occurring in the last stages of pregnancy and related to intrauterine posture position are not uncommon in multiple pregnancies (Arıoğlu Aydın et al., 2016).
Since MZT pregnancies increase the risk of maternal and infant mortality and may entail many complications, sharing data from ART treatments is important to ensure the adoption of strict treatment standards and to monitor perinatal risks. The present study describes our assisted reproductive technology (ART) procedures from the viewpoint of perinatal outcomes in MZT pregnancies.

MATERIALS AND METHODS

Study Design
We retrospectively evaluated 1159 cycles included in the ICSI program of the Department of Obstetrics and Gynecology, Faculty of Medicine, between October 2014 and December 2019. We analyzed the perinatal outcomes and general clinical conditions of all monozygotic pregnancies. This retrospective clinical cross-sectional study was conducted following approval by the Bahcesehir University Ethics Committee (17.07.2020-0003). The experiment protocol was developed in accordance with national, international, and institutional guidelines for studies involving human beings and complied with the principles of the Declaration of Helsinki. Informed consent was obtained from all subjects and the data collected included basic patient clinical condition, delivery results, type of conception, and pregnancy outcomes. Patient data were obtained from the retrospective examination of test results and inpatient treatment charts. The cases included in the study were evaluated in terms of average age of pregnant women, average gestational week, delivery type, birth weight, presence of EMR, gender, cesarean indications, miscarriage, fetal problems, fetal reduction, discordance between fetuses, pregnancy anemia, blood transfusion to mother, cerclage, abortus imminens, emesis gravidarum, BMI.

Inclusion & Exclusion Criteria
Women were identified through the use of an electronic database. The result of all clinical and ultrasound examinations were considered and only MZT pregnancies reaching week 16 of gestation were included. Other types of pregnancy or related conditions were excluded from the present study. In detailed ultrasound analysis, pregnancies were accepted as monochorionic based on the presence of placenta and the absence of the twin peak mark known as the “lambda sign”. An experienced team of gynecologists specialized in obstetric sonography and IVF performed the clinical assessments and ultrasound examinations of the patients.

Statistical Analysis
The SPSS program for Windows (v16.0, SPSS Inc. Illinois,USA) was used to evaluate the study results. Descriptive statistics outputs were given as mean ± standard deviation for continuous numerical variables or median (minimum-maximum) and percentage for categorical variables. Comparative analysis was done with the Mann-Whitney U test for continuous data and the χ2 test for categorical data. p<0.05 was considered statistically significant in data assessment.

RESULTS
Sixteen of the 1159 IVF cycles resulted in MZT pregnancy, yielding an incidence of 1.38%. The incidence of MZT pregnancy in individuals aged ≤35 and >35 years were 0.2% and 1.1%, respectively. As seen in Table 1, the main reason for infertility was male-related factors (n:7). Other reasons were endometriosis (n:3), Duchenne muscular dystrophy (n:2), tubal (n:1), and unexplained (n:3). Female patients were aged 29.8±3.4 years and males were aged 33.7±3.2 years on average. The mean BMI was 24.2±2.3 kg/m². The mean number of attempts was 2.1±2.2 and the mean AMH level was 2.4±1.7.

Table 1. Patient demographic data.

Eight MZT pregnancies resulted in live births. Two of them were triplet pregnancies (25%). Five MZT pregnancies resulted in miscarriage. Two of them were triplet pregnancies (40%). Three MZT pregnancies, which were twin pregnancy, resulted in partial abortion. Table 2 shows ART cycle characteristics.

Table 2. Patient outcomes with oocyte and trigger details Trigger Agent.

A significant positive correlation was found between the number of attempts and the age of the female (r:0.674; p=0.004) and male (r:0.657; p=0.006) partners. Similarly, Cumulus-Oocytes Complexes (COC) (r:0.635; p=0.008), Metaphase II Oocyte (MIIO) (r:0.627; p=0.009), Pronucleus Oocyte (PO) (r:0.585; p=0.017) were correlated with serum AMH levels. Number of MZT was positively correlated with the male age (r:0.527; p=0.036) and negatively correlated with embryo transfer day (ETd) (r:-0.548; p=0.028).

DISCUSSION
The need to develop their careers has led many couples to delay their plans of having children. A growing number of couples seek ART treatments at a more advanced age. Although a rare event, previous studies have reported that the incidence of MZT has increased more than four times as a result of IVF procedures, with an increased risk of obstetric complications and poor pregnancy outcomes (Delrieu et al., 2012; Franasiak et al., 2015; Gee et al., 2014). For these reasons, MZT pregnancies may become a problem as the number of individuals seeking IVF continues to increase. In that term, the present study will contribute to the MZT numbers resulting from the application of IVF in our country and the perinatal clinical outcomes of MZT.
Despite the troublesome effects of MZT pregnancies, in many clinics there still is a preference for transferring multiple embryos to increase the chance of pregnancy (Tummers et al., 2003). Decreased fertility possibly occurs mainly due to oocyte aging rather than poor endometrial receptivity. Older women produce fewer oocytes and have lower implantation rates, suggesting that follicles are less responsive to exogenous hormones, which ultimately leads to the retrieval of fewer high-quality oocytes (Chuang et al., 2003). Sotiroska et al. (2015) found higher pregnancy rates in individuals receiving ET on the 5^thday. However, they observed a strong decrease in delivery/pregnancy rates in older individuals (age >36 years) compared to younger ones. This suggests that older women have a lower chance of conceiving through assisted reproductive technology, despite having low basal FSH levels. In the present study, the number of MZT was positively correlated with male age and negatively correlated with embryo transfer day. A significant positive correlation was found between the number of attempts and age of female and male partners.
Recent studies have looked into various aspects of IVF procedures, parent age, hormone levels, and anatomical problems previously associated with the incidence of MZT pregnancies. According to Knopman et al. (2014), the likelihood of having an MZT pregnancy was linked to the possibly superior reproductive potential of younger individuals reflected in the supply of healthier oocytes. Although logical, there is still a lot of uncertainty in this explanation and more data is needed. Embryos derived from younger oocytes are transferred in the blastocyst stage of the advanced levels. This because age factor may not be an independent risk factor for MZT, but rather a representative of blastocyst transfer (Knopman et al., 2014). In the study by Sills et al., the incidence of MZT pregnancies was 1.3%, a proportion comparable to reported results and three times higher than the incidence of naturally conceived MZT pregnancies, described as 0.4% (Sills et al., 2000). Vega et al. (2018), in the largest study of IVF cycles evaluating multiple pregnancies, dizygotic, and discordant twinning rates, reported a rate of MZT pregnancies in women aged <35 years of 1.7%. Osianlis et al. (2014) analyzed a large single-institution database and determined that cycles carried a 2.3% risk of multiple pregnancies. In our study with 1159 IVF cycles, sixteen resulted in MZT pregnancies, an incidence of 1.38%. The incidence of MZT pregnancies in women aged ≤35 and >35 were 0.2% and 1.1%, respectively.
As a result, high-risk results in terms of maternal and infant health can occur in IVF. Shevell et al. (2005) detected an increased abnormal placentation rate in IVF and assumed that it may cause complications during pregnancy. Romundstad et al. (2006) found that placenta previa occurs six times more frequently in singleton pregnancies after ART procedures. Zhu et al. (2016) reported abnormal placental cord placement in women who gave birth after ART procedures versus matched controls with spontaneous pregnancies. Considering these studies, it has been suggested that MZT pregnancy may cause poor maternal outcomes and stillbirths resulting from inadequate or abnormal placental development. In our study, we observed that eight MZT pregnancies resulted in live births. Five MZT pregnancies resulted in miscarriage. Three MZT pregnancies - twin pregnancies - resulted in partial abortion. These MZT pregnancy outcomes corroborate the existence of increased maternal risk described in the literature.
The effect of low AMH levels on oocyte quality is known. However, the possibility that the association between AMH and the presence of oocyte defects may result from decreased granulose secretion in poor quality oocytes remains an important issue that continues to be investigated. AMH levels may influence the determination of the dominant follicle through the inhibitory effects of AMH during the primary follicle collection process from the primordial pool (Durlinger et al., 2001) and regulation of FSH sensitivity in ovarian tissue (Kevenaar et al., 2007). Borges et al. (2017) and Fanchin et al. (2007) examined whether follicular AMH production was positively associated with oocyte and embryo development and demonstrated its significant effect. Ebner et al. (2006) showed that AMH levels are directly and strongly associated with oocyte quality. Loh & Maheshwari (2011) explained that AMH did not predict the likelihood of pregnancy. La Marca et al. (2011) reported that extremely low levels of AMH were associated with inability to conceive. Lamazou et al. (2011) found reasonable pregnancy rates following extremely low serum AMH levels. Borges et al. (2017) showed that the probability of pregnancy and the number of embryos obtained, high-quality embryos, and the number of embryos transferred were positively correlated with AMH level. Similarly, in the present study, we found that cumulus-oocytes complexes, metaphase-II oocytes, and pronucleus oocytes were strongly correlated with serum AMH levels.
The present study has its limitations. Not all patient data related to risk factors for MZT pregnancies resulting from ART procedures were identified in this retrospective study. Another point is the fact that the number of women who achieve pregnancy with the aid of IVF or through natural conception may vary according to demographic variables potentially associated with MZT pregnancy. Since being a young female is directly connected with having MZT pregnancy after ART, we cannot exclude the possibility of having underestimated the risk. This limitation is generally seen in clinical observational analysis in different medical fields. In the present study, however, it should be noted that although some confounders cannot be ruled out, the magnitude of the risk tends to support the existence of a causal effect.

CONCLUSION
The incidence of MZT pregnancy among the IVF patients included in our study was similar to the incidence reported in the literature, although risk was more pronounced in women aged >35 years. A strong positive correlation was found between the number of attempts and the age of the female and male partners. The number of MZT pregnancies was positively correlated with male age and negatively correlated with embryo transfer day. As a result, MZT pregnancies may become a problem as the number of individuals seeking IVF continues to increase due to its potential risks for both maternal and fetus.

Ethics approval and consent to participate: The study was approved by the Ethics Committee at Bahcesehir Univercity with the date and number: 17.07.2020-0003. Informed consent was obtained from all subjects.
Consent for publication: Approved by Bahcesehir University (17 July 2020).

REFERENCES
Aboulghar MM, El-Faissal Y, Kamel A, Mansour R, Serour G, Aboulghar M, Islam Y. The effect of early administration of rectal progesterone in IVF/ICSI twin pregnancies on the preterm birth rate: a randomized trial. BMC Pregnancy Childbirth. 2020;20:351. PMID: 32517660 DOI: 10.1186/s12884-020-03033-4 Medline

Arıoğlu Aydın Ç, Aydın S, Serdaroğlu H. Multifetal gestations with assisted reproductive technique before the single-embryo transfer legislation: obstetric, neonatal outcomes and congenital anomalies. J Matern Fetal Neonatal Med. 2016;29:2475-80. PMID: 26414487 DOI: 10.3109/14767058.2015.1090422 Medline

Ballesta-Castillejos A, Gomez-Salgado J, Rodriguez-Almagro J, Ortiz-Esquinas I, Hernández-Martínez A. Obstetric and perinatal complications associated with assisted reproductive treatment in Spain. J Assist Reprod Genet. 2019;36:2435-45. PMID: 31741255 DOI: 10.1007/s10815-019-01631-6 Medline

Borges E, Braga DPAF, Setti A, Figueira RC, Iaconelli A Jr. The predictive value of serum concentrations of anti-Müllerian hormone for oocyte quality, fertilization, and implantation. JBRA Assist Reprod. 2017;21:176-82. PMID: 28837024 DOI: 10.5935/1518-0557.20170035 Medline

Cakiroglu Y, Tiras B. Determining diagnostic criteria and cause of recurrent implantation failure. Curr Opin Obstet Gynecol. 2020;32:198-204. PMID: 32251092 DOI: 10.1097/GCO.0000000000000620 Medline

Calik KY, Bulut HK. Assessment of Turkey IVF (In Vitro Fertilization) websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines. J Pak Med Assoc. 2020;70:421-6. PMID: 32207418 DOI: 10.5455/JPMA.293892 Medline

Cavoretto P, Candiani M, Giorgione V, Inversetti A, Abu-Saba MM, Tiberio F, Sigismondi C, Farina A. Risk of spontaneous preterm birth in singleton pregnancies conceived after IVF/ICSI treatment: meta-analysis of cohort studies. Ultrasound Obstet Gynecol. 2018;51:43-53. PMID: 29114987 DOI: 10.1002/uog.18930 Medline

Chuang CC, Chen CD, Chao KH, Chen SU, Ho HN, Yang YS. Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization. Fertil Steril. 2003;79:63-8. PMID: 12524065 DOI: 10.1016/S0015-0282(02)04562-4 Medline

Delrieu D, Himaya E, Phillips S, Kadoch IJ. Monozygotic multiple pregnancies following IVF: a case report series of rare experience. Reprod Biomed Online. 2012;25:460-5. PMID: 22871949 DOI: 10.1016/j.rbmo.2012.06.019 Medline

Dobrosavljevic A, Rakic S, Mihajlovic S. Risk of spontaneous preterm labor in pregnancies achieved by in vitro fertilization and complicated with severe form of ovarian hyperstimulation syndrome: A case control study. Pak J Med Sci. 2019;35:923-8. PMID: 31372118 DOI: 10.12669/pjms.35.4.145 Medline

Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP. Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology. 2001;142:4891-9. PMID: 11606457 DOI: 10.1210/endo.142.11.8486 Medline

Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G. Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod. 2006;21:2022-6. PMID: 16679324 DOI: 10.1093/humrep/del127 Medline